According to Guyton's model, impaired renal
sodium excretion plays a key role in the increased
salt sensitivity of blood pressure (BP). Several factors contribute to impaired renal
sodium excretion, including the sympathetic nervous system, the renin-angiotensin system and
aldosterone. Accumulating evidence suggests that abnormalities in
aldosterone and its receptor (i.e. the
mineralocorticoid receptor (MR)) are involved in the development of
salt-sensitive (SS)
hypertension. Patients with
metabolic syndrome often exhibit
hyperaldosteronism and are susceptible to SS
hypertension.
Aldosterone secretion from the adrenal glands is not suppressed in obese hypertensive rats fed a high-
salt diet because of the abundant production of adipocyte-derived
aldosterone-releasing factors, which are independent of the negative feedback regulation of
aldosterone secretion by the renin-angiotensin-aldosterone system. Increased plasma
aldosterone levels lead to SS
hypertension via MR activation in the kidney. Renal MR activity is increased in Dahl salt-sensitive rats fed a high-
salt diet, despite the appropriate suppression of plasma
aldosterone levels. In this rat strain, activation of MR in the distal nephron causes
salt-induced
hypertension. This paradoxical response of the MR to
salt loading can be attributed to activation of Rac1, a
small GTPase. In the presence of
aldosterone, activated Rac1 synergistically and directly activates MR in a
ligand-independent manner. Thus, Rac1 activation in the kidney determines the
salt sensitivity of BP. Together, the available evidence suggests that the aberrant Rac1-MR pathway plays a key role in the development of SS
hypertension.